Horizon Pharma plc Provides Update on Relationship With Specialty Pharmacies

Horizon Pharma plc Provides Update on Relationship With Specialty Pharmacies

ID: 428614

(firmenpresse) - DUBLIN, IRELAND -- (Marketwired) -- 10/21/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today provided an update on its relationship with specialty pharmacies:

Horizon primary care and specialty medicines are distributed by both specialty and retail pharmacies.

All pharmacies that distribute Horizon branded medicines are fully independent. Horizon does not own or have an ownership stake in any pharmacy and does not possess an option to purchase any pharmacy. In addition, the relationship with these pharmacies is non-exclusive where each of these pharmacies may also fulfill prescriptions for other drug manufacturers.

Consistent with most pharmaceutical companies, Horizon sells medicines to wholesalers and receives sales proceeds from the wholesaler. Horizon does not own or have any ownership stake in any drug wholesaler nor does Horizon possess an option to purchase any wholesaler.

Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon's global headquarters are in Dublin, Ireland. For more information, please visit . Follow on Twitter or view careers on our page.



Investors:
John Thomas
Executive Vice President, Strategy and Investor Relations


Tina Ventura
Vice President, Investor Relations


U.S. Media Contact:
Geoff Curtis
Group Vice President, Corporate Communications


Ireland Media Contact:
Ray Gordon
Gordon MRM



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Theravance to Report Third Quarter 2015 Financial Results on October 28, 2015 Insys Therapeutics to Report Third Quarter 2015 Results
Bereitgestellt von Benutzer: Marketwired
Datum: 21.10.2015 - 21:55 Uhr
Sprache: Deutsch
News-ID 428614
Anzahl Zeichen: 0

contact information:
Town:

DUBLIN, IRELAND



Kategorie:

Drugs



Diese Pressemitteilung wurde bisher 308 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Horizon Pharma plc Provides Update on Relationship With Specialty Pharmacies"
steht unter der journalistisch-redaktionellen Verantwortung von

Horizon Pharma plc (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Horizon Pharma plc



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z